More than half of US adults are eligible for primary prevention with statins, yet lipid-lowering therapies remain underused.

With expectations to work after hours and a growing administrative burden, some say “radical” action is needed.

The FLASH protocol, associated with less radiation than a CAC scan, should be used more often in this cohort, a researcher ...

Results from the DAPT-MVD trial, while not necessarily generalizable, do open the door to a new tactic in select cases.

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

In addition to giving patients standard verbal breath-holding instructions, the segment offers them an idea of what to expect ...

Recommendations around dosing, duration, and patient-specific options are woven into the fabric of the scientific statement.

The meeting offers something for all: from the practicalities of running a cardiac CT program to the effect of AI on the ...

The tools may help address underdiagnosis in this area, though there is still room for improvement in screening performance.

The pilot study provides “a good illustration of how AI can be an augmentation to our current processes,” Thomas Maddox says.

The US Food and Drug Administration has approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for reducing LDL ...

Differences in various efficiency metrics were modest, but “minutes matter in stroke,” Shyam Prabhakaran says.